253 related articles for article (PubMed ID: 37109574)
1. Regulation of Cell Proliferation and Nrf2-Mediated Antioxidant Defense: Conservation of Keap1 Cysteines and Nrf2 Binding Site in the Context of the Evolution of KLHL Family.
Shilovsky GA; Dibrova DV
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109574
[TBL] [Abstract][Full Text] [Related]
2. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
Wakabayashi N; Dinkova-Kostova AT; Holtzclaw WD; Kang MI; Kobayashi A; Yamamoto M; Kensler TW; Talalay P
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2040-5. PubMed ID: 14764894
[TBL] [Abstract][Full Text] [Related]
3. The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613.
Hourihan JM; Kenna JG; Hayes JD
Antioxid Redox Signal; 2013 Aug; 19(5):465-81. PubMed ID: 23145493
[TBL] [Abstract][Full Text] [Related]
4. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.
Eggler AL; Liu G; Pezzuto JM; van Breemen RB; Mesecar AD
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10070-5. PubMed ID: 16006525
[TBL] [Abstract][Full Text] [Related]
5. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
Zhang DD; Hannink M
Mol Cell Biol; 2003 Nov; 23(22):8137-51. PubMed ID: 14585973
[TBL] [Abstract][Full Text] [Related]
6. C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape.
Dayalan Naidu S; Muramatsu A; Saito R; Asami S; Honda T; Hosoya T; Itoh K; Yamamoto M; Suzuki T; Dinkova-Kostova AT
Sci Rep; 2018 May; 8(1):8037. PubMed ID: 29795117
[TBL] [Abstract][Full Text] [Related]
7. Critical cysteine residues of Kelch-like ECH-associated protein 1 in arsenic sensing and suppression of nuclear factor erythroid 2-related factor 2.
He X; Ma Q
J Pharmacol Exp Ther; 2010 Jan; 332(1):66-75. PubMed ID: 19808700
[TBL] [Abstract][Full Text] [Related]
8. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
[TBL] [Abstract][Full Text] [Related]
9. Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury.
Cheng Y; Cheng L; Gao X; Chen S; Wu P; Wang C; Liu Z
Theranostics; 2021; 11(2):861-877. PubMed ID: 33391509
[No Abstract] [Full Text] [Related]
10. Identification and characterization of novel Nrf2 inducers designed to target the intervening region of Keap1.
Wu JH; Miao W; Hu LG; Batist G
Chem Biol Drug Des; 2010 May; 75(5):475-80. PubMed ID: 20486933
[TBL] [Abstract][Full Text] [Related]
11. NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation.
He X; Ma Q
Mol Pharmacol; 2009 Dec; 76(6):1265-78. PubMed ID: 19786557
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
Unni S; Deshmukh P; Krishnappa G; Kommu P; Padmanabhan B
FEBS J; 2021 Mar; 288(5):1599-1613. PubMed ID: 32672401
[TBL] [Abstract][Full Text] [Related]
13. Modification of keap1 cysteine residues by sulforaphane.
Hu C; Eggler AL; Mesecar AD; van Breemen RB
Chem Res Toxicol; 2011 Apr; 24(4):515-21. PubMed ID: 21391649
[TBL] [Abstract][Full Text] [Related]
14. Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish.
Li L; Kobayashi M; Kaneko H; Nakajima-Takagi Y; Nakayama Y; Yamamoto M
J Biol Chem; 2008 Feb; 283(6):3248-3255. PubMed ID: 18057000
[TBL] [Abstract][Full Text] [Related]
15. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.
Furukawa M; Xiong Y
Mol Cell Biol; 2005 Jan; 25(1):162-71. PubMed ID: 15601839
[TBL] [Abstract][Full Text] [Related]
16. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK
J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
[TBL] [Abstract][Full Text] [Related]
18. Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism.
Kansanen E; Bonacci G; Schopfer FJ; Kuosmanen SM; Tong KI; Leinonen H; Woodcock SR; Yamamoto M; Carlberg C; Ylä-Herttuala S; Freeman BA; Levonen AL
J Biol Chem; 2011 Apr; 286(16):14019-27. PubMed ID: 21357422
[TBL] [Abstract][Full Text] [Related]
19. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
[TBL] [Abstract][Full Text] [Related]
20. The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system.
Copple IM; Goldring CE; Jenkins RE; Chia AJ; Randle LE; Hayes JD; Kitteringham NR; Park BK
Hepatology; 2008 Oct; 48(4):1292-301. PubMed ID: 18785192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
